Galapagos | 营业费用



Operating Expenses 更改 日
argenx SE USD 744.12M 92.38M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Biogen USD 1.79B 326.1M 2025-06
Genmab DKK 527M 3.72B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.96B 663M 2025-06
GRIFOLS EUR 1.54B 24.64M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Incyte USD 904.7M 56.97M 2025-06
Merck EUR 4.27B 51M 2025-03
Neurocrine Biosciences USD 541.9M 7M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 2.36B 108M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12


Galapagos 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.